Engineering Saccharomyces cerevisiae for the production of dihydroquercetin from naringenin

Shiqin Yu,Mingjia Li,Song Gao,Jingwen Zhou
DOI: https://doi.org/10.1186/s12934-022-01937-8
IF: 6.352
2022-10-17
Microbial Cell Factories
Abstract:Dihydroquercetin (DHQ), a powerful bioflavonoid, has a number of health-promoting qualities and shows potential as a treatment for a number of disorders. Dihydroquercetin biosynthesis is a promising solution to meet the rising demand for dihydroquercetin. However, due to the significant accumulation of eriodietyol (ERI), naringenin (NAR), dihydrokaempferol (DHK), and other metabolites, the yield of DHQ biosynthesis is low. As a result, this is the hindrance to the biosynthesis of DHQ.
biotechnology & applied microbiology
What problem does this paper attempt to address?